Aker BioMarine ASA (OSL:AKBM)

Norway · Delayed Price · Currency is NOK

111.60

+1.80 (1.64%)

At close: Mar 13, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Human Health Ingredients	118.10M	97.90M	83.70M	-	-
Human Health Ingredients Growth	20.63%	16.97%	-	-	-
Consumer Health Products	108.50M	109.40M	122.20M	-	-
Consumer Health Products Growth	-0.82%	-10.47%	-	-	-
Emerging Businesses	8.20M	9.70M	11.10M	-	-
Emerging Businesses Growth	-15.46%	-12.61%	-	-	-
Other/Eliminations	-	-18.10M	-20.70M	-14.30M	-17.90M
Ingredients	-	-	-	176.60M	169.60M
Ingredients Growth	-	-	-	4.13%	-14.52%
Brands	-	-	-	114.90M	110.40M
Brands Growth	-	-	-	4.08%	5.73%
Total	234.80M	198.90M	196.30M	277.20M	262.10M
Total Growth	18.05%	1.32%	-29.18%	5.76%	-9.18%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Norway	5.10M	200.00K	26.80M	22.90M
Norway Growth	2450.00%	-99.25%	17.03%	10.32%
EMEA	15.90M	15.40M	50.90M	54.00M
EMEA Growth	3.25%	-69.74%	-5.74%	52.97%
Americas	140.80M	145.70M	144.30M	138.60M
Americas Growth	-3.36%	0.97%	4.11%	-5.63%
Asia Pacific	37.20M	35.00M	55.20M	46.60M
Asia Pacific Growth	6.29%	-36.59%	18.45%	-45.60%
Total	199.00M	196.30M	277.20M	262.10M
Total Growth	1.38%	-29.18%	5.76%	-9.18%

Source: S&P Global Market Intelligence.